NxStage Voluntary Sak Recall
Higher levels of endotoxin than NxStage tolerates were found in less than 1% of affected sak lots, so they notified patients who had those lots and issued a voluntary recall. An FDA recall was not required.
Read the full article » | Posted 02-15-2018
Related Articles
- Education Critical to Boosting Home Dialysis, Panel Says I Posted 01-16-2026
- The Annual Dialysis Conference Will be in Kansas City, MO February 26 to March 1 Posted 01-16-2026
- The Forum of ESRD Networks has New Videos for its 2023 Home Dialysis Toolkit Posted 01-16-2026
- Vantive: Real People, Real Stories on PD Empowers Site for Patients Posted 12-17-2025

